The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

Lupin receives USFDA approval for its generic version of Ivacaftor oral granules, a treatment for cystic fibrosis. The ...

India has the potential to increase exports of organic products up to Rs 20,000 crore in the next three years, Commerce and ...

The Delhi High Court on Friday issued notice to Dabur India Limited on a plea filed by Tata Group owned Capital Foods for ...

What initially stands out to me about Hims & Hers is the company's distinct branding and feel of luxury, which is evident on ...

According to the most recent exchange filing, Sudarshan Pharma Industries Ltd., a leading contract maker of speciality ...

Despite concerns over cabozantinib's patent expiry, Exelixis projects robust future revenues, with lead pipeline candidate ...

A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.

Beyond the influence of new therapies on drug pricing trends, Cowen’s report also accounted for the effects of legislation ...

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

The US FDA approved the first generic referencing Victoza, a GLP-1 receptor agonist indicated to improve glycemic control.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...